Skip to content

Author

Danielle R. Wendel

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials

Background Teduglutide can reduce dependence on parenteral nutrition and/or intravenous fluids (PN/IV) in children with short bowel syndrome-associated intestinal failure (SBS-IF). Material and methods A post-hoc analysis was conducted using data from open-label long-term extension (LTE) trials (NCT02949362, NCT0295445...

S. Hill, Beth Carter, Valeria C. Cohran et al. · 0 citations
Open access Sep 2026

Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study.

In children treated with teduglutide, a progressive and sustained reduction in parenteral support up to 3 years is found and careful monitoring of nutritional status while on this new medication is warranted.

Lissette Jimenez, Aliza Ray, David F. Mercer et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.